The European Food Safety Authority launches a safety assessment for NMN as a novel food, with the application coming from a Chinese company.

July 25, 2025— The European Food Safety Authority (EFSA) has recently launched a safety assessment of β-nicotinamide mononucleotide (NMN) as a novel food, with the public consultation document numbered PC-1537, applied by Shanghai Shangke Biotechnology, China. This move marks the formal entry of NMN, a highly anticipated anti-aging ingredient, into the European Union's regulatory review process. If approved, it will become the first NMN ingredient legally used across the EU, triggering the global anti-aging market. (1) The target population for this novel food is adults, used as a dietary supplement; (2) The maximum daily usage is 500mg/day; (3) The deadline for public consultation is August 12, 2025. Core information of the application: The rigorous clearance from laboratory to food According to the information released by EFSA, this application falls under the category of "Novel Food," which refers to food ingredients not widely consumed in the EU before May 15, 1997. NMN, as a ...